APOE and Alzheimer disease: However, when compared to a previous study (AUC = 0.91, P < 0.001) that combined plasma P-tau217, memory, executive function, and APOE, our results indicated that plasma sEV miRNA biomarkers were not more advantageous in AD diagnosis than traditional biomarkers [33].